Olympus Small Animal Imaging System Specifications
The OV100 is a new imaging system that allows researchers to observe fluorescent markers in live animals at the whole animal, organ, tissue, and single cell level, with a single optical instrument. The OV100 provides a 114:1 zoom ratio change and features superior optics for high resolution and efficiency of light collection. The OV100 integrates many basic needs of whole animal imaging including the removal of auto-fluorescence background and high performance in the NIR range up to 1000nm for fluorescence detection. The OV100 also allows the user to choose a CCD camera to meet the specific demands of their research i.e. high resolution, high speed, or low light sensitivity.
| |
High
magnification mode |
Low
magnification mode (3 individual parcentered and
parfocal lenses) |
| Zoom |
1 |
2 |
3 |
| Magnification |
Optical
magnification |
1.6—16X |
0.89X |
0.56X |
0.14X |
| Observation |
Observation
range (mm) |
5.5
X 4.1—0.5 X 0.4 |
9.9
X 7.4 |
16
X 12 |
63
X 47 |
| |
WD
(mm) |
33.5 |
65 |
87 |
240 |
| NA |
0.43—0.046 |
0.25 |
0.15 |
0.039 |
| Resolution
(ìm) |
1.75—7.0 |
9.9 |
20 |
63 |
| Observational
Channel |
Brightfield,
GFP, RFP, 680, 750 |
| Illumination |
Light
source for fluorescence excitation |
Xe
or Hg-Xe lamp housing (150W), 8-position excitation
filter (diam. 25mm) |
Fluorescence
image acquisition |
6-position
emission filter (diam. 32mm) |
Illumination
for brightfield |
Light
guide. Light source: 100W Halogen lamp |
| Stage |
High-precision
motorized X, Y stage (Position reproducibility: ±10µm) |
| Focusing |
Stage
focus |
| Camera
Port |
C-mount |
| Software |
Acquisition
of still images and movies via special CCD camera
software. Post acquisition image processing and
analysis |
| Power
consumption |
PC:
7.1A Body: 8.5A |
| Dimensions |
Body:
550(W) X 554(D) X 1000(H)mm, Desk (with caster): 1200
(W) X 700(D) X 600(H)mm |
| Weight |
Approx.
100kg |
Notice: The OV100 imaging system has many potential applications. Certain of these applications and materials used with them may require licensing under patents held by third parties. For example AntiCancer, Inc. (http://www.anticancer.com) and Xenogen Corporation (http://www.xenogen.com) each own several patents in the field of imaging cells genetically engineered to produce light-emitting compounds. Olympus has obtained a license from AntiCancer, such that non-profit entities purchasing the OV100 are licensed under AntiCancer U.S. Patent Nos. 6,232,523, 6,649,159, 6,235,968, 6,251,384, and 6,759,038 for non-commercial uses. Olympus' sale or other transfer of the OV100 imaging system does not convey any additional rights or licenses under third party patents. It is suggested that users of the OV100 imaging system consult with counsel to determine whether licensing of additional third party patents is required.
|